title: The α2-adrenergic receptor agonist, clonidine, reduces alcohol drinking in alcohol-preferring (P) rats.
abstract: Evidence suggests that noradrenergic signaling may play a role in mediating alcohol-drinking behavior in both rodents and humans. We have investigated this possibility by administering clonidine to alcohol-drinking rats selectively bred for alcohol preference (P line). Clonidine is an α2-adrenergic receptor agonist which, at low doses, inhibits noradrenergic signaling by decreasing norepinephrine release from presynaptic noradrenergic neurons. Adult male P rats were given 24 h access to food and water and scheduled access to a 15% (v/v) alcohol solution for 2 h daily. Rats received intra-peritoneal (IP) injections with clonidine (0, 10, 20, 40, or 80 μg/kg body weight [BW], 10-11 rats/treatment group) once/day at 30 min prior to onset of the daily 2 h alcohol access period for 2 consecutive days. Clonidine, in doses of 40 or 80 μg/kg BW, significantly reduced alcohol intake on both days of treatment (p<0.001). Two weeks later, rats were treated with clonidine for 5 consecutive days and clonidine, in doses of 40 or 80 μg/kg BW, reduced alcohol intake on all 5 treatment days (p < 0.001). Clonidine did not alter water consumption during the daily 2 h free-choice between alcohol and water. In a separate group of male P rats, clonidine (40 μg/kg BW) suppressed intake of a saccharin solution (0.04 g/L). These results are consistent with and complement our previous findings that the α1-adrenergic receptor antagonist, prazosin, decreases voluntary alcohol drinking in alcohol-preferring rats, but suggests that effects of clonidine may not be specific for alcohol. The results suggest that although activation of the noradrenergic system plays an important role in mediating voluntary alcohol drinking, care is needed in selecting which drugs to use to suppress central noradrenergic signaling in order to maximize the selectivity of the drugs for treating alcohol-use disorders.
authors.affiliation: VISN 20 Mental Illness Research Education and Clinical Center, VA Puget Sound Health Care System; University of Washington, Seattle, WA 98195, USA. Electronic address: drasmuss@u.washington.edu.
authors.forename: Dennis D
authors.initials: DD
authors.lastname: Rasmussen
authors.affiliation: Indiana University School of Medicine, Indianapolis, IN 46202, USA.
authors.forename: Laura
authors.initials: L
authors.lastname: Alexander
authors.affiliation: Indiana University School of Medicine, Indianapolis, IN 46202, USA.
authors.forename: Julia
authors.initials: J
authors.lastname: Malone
authors.affiliation: Indiana University School of Medicine, Indianapolis, IN 46202, USA.
authors.forename: David
authors.initials: D
authors.lastname: Federoff
authors.affiliation: Indiana University School of Medicine, Indianapolis, IN 46202, USA.
authors.forename: Janice C
authors.initials: JC
authors.lastname: Froehlich
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000627:therapeutic use*; D000428:Alcohol Drinking / Q000188:drug therapy*; D000818:Animals; D002755:Choice Behavior; D003000:Clonidine / Q000627:therapeutic use*; D004326:Drinking / Q000187:drug effects; D008297:Male; D051381:Rats; D012439:Saccharin / Q000008:administration & dosage
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D012439:Saccharin; D003000:Clonidine
keywords: Alcohol; Clonidine; Ethanol; Noradrenergic; Norepinephrine; P rat
references.citation: Alcohol. 2008 Mar;42(2):91-7
references.pmid: 18358987
references.citation: Pharmacol Biochem Behav. 2009 Jan;91(3):295-302
references.pmid: 18703080
references.citation: Science. 1984 Nov 16;226(4676):864-6
references.pmid: 6387913
references.citation: Psychol Med. 1994 Feb;24(1):69-80
references.pmid: 8208896
references.citation: Psychopharmacology (Berl). 1995 Dec;122(4):369-73
references.pmid: 8657835
references.citation: Drug Alcohol Depend. 1990 Feb;25(1):43-8
references.pmid: 1969792
references.citation: J Pharmacol Toxicol Methods. 2007 Sep-Oct;56(2):256-64
references.pmid: 17618130
references.citation: Psychopharmacology (Berl). 1998 Jun;137(4):311-20
references.pmid: 9676889
references.citation: Brain Res Bull. 1981 Dec;7(6):661-4
references.pmid: 7326582
references.citation: Am J Psychiatry. 1999 May;156(5):723-32
references.pmid: 10327905
references.citation: Br J Pharmacol. 1982 Jan;75(1):251-4
references.pmid: 7074285
references.citation: Biol Psychiatry. 2005 May 15;57(10):1202-4
references.pmid: 15866561
references.citation: Science. 1997 Oct 3;278(5335):52-8
references.pmid: 9311926
references.citation: Alcohol Clin Exp Res. 2013 Sep;37(9):1552-60
references.pmid: 23731093
references.citation: Eur Neuropsychopharmacol. 2008 Apr;18(4):303-11
references.pmid: 17920248
references.citation: Arch Int Pharmacodyn Ther. 1977 Nov;230(1):76-82
references.pmid: 603311
references.citation: Alcohol Clin Exp Res. 2013 Oct;37(10):1763-70
references.pmid: 23875623
references.citation: Pharmacol Biochem Behav. 1999 Apr;62(4):585-9
references.pmid: 10208362
references.citation: Psychopharmacology (Berl). 2005 May;179(2):366-73
references.pmid: 15551068
references.citation: Q J Stud Alcohol. 1972 May;6:Suppl 6:94-119
references.pmid: 5031418
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1974;285(2):133-50
references.pmid: 4155791
references.citation: Eur J Neurosci. 2000 Jan;12(1):292-302
references.pmid: 10651884
references.citation: Science. 1982 Mar 12;215(4538):1394-6
references.pmid: 6278591
references.citation: Pharmacol Biochem Behav. 1983 Oct;19(4):687-91
references.pmid: 6647504
references.citation: J Am Med Assoc. 1959 May 9;170(2):197-203
references.pmid: 13641007
references.citation: Br J Pharmacol. 1980;71(2):473-8
references.pmid: 7470758
references.citation: Neuropsychopharmacology. 2001 Sep;25(3):320-31
references.pmid: 11522461
references.citation: Acta Psychiatr Scand. 1975 Oct;52(4):256-63
references.pmid: 1103576
references.citation: Eur J Clin Pharmacol. 1983;24(1):21-30
references.pmid: 6832197
references.citation: Alcohol Clin Exp Res. 2009 Feb;33(2):255-63
references.pmid: 18945226
references.citation: Alcohol Clin Exp Res. 2001 Jul;25(7):999-1005
references.pmid: 11505024
references.citation: Neuropsychopharmacology. 2000 Aug;23(2):138-50
references.pmid: 10882840
references.citation: Alcohol Clin Exp Res. 2009 Feb;33(2):264-72
references.pmid: 19032582
references.citation: Alcohol Clin Exp Res. 2009 Mar;33(3):408-18
references.pmid: 19120051
references.citation: Psychol Med. 1998 Jul;28(4):773-88
references.pmid: 9723135
references.citation: Ann N Y Acad Sci. 1981;362:191-202
references.pmid: 7020529
references.citation: Am J Psychiatry. 1990 Jun;147(6):685-95
references.pmid: 2188513
references.citation: Psychopharmacology (Berl). 2007 Sep;193(4):457-65
references.pmid: 17486319
references.citation: Alcohol. 2006 Apr;38(3):173-7
references.pmid: 16905443
references.citation: Alcohol Clin Exp Res. 2014 Jun;38(6):1532-9
references.pmid: 24891220
references.citation: Psychopathology. 1984;17 Suppl 1:83-97
references.pmid: 6369370
references.citation: Arch Int Pharmacodyn Ther. 1977 Nov;230(1):65-75
references.pmid: 603310
references.citation: Biol Psychiatry. 1999 Nov 1;46(9):1205-18
references.pmid: 10560026
references.citation: Pharmacol Biochem Behav. 1978 Sep;9(3):369-74
references.pmid: 714985
references.citation: Pharmacol Biochem Behav. 1988 Jul;30(3):769-73
references.pmid: 3211986
references.citation: Mol Pharmacol. 2009 May;75(5):1160-70
references.pmid: 19251826
references.citation: Neuropsychopharmacology. 2007 Mar;32(3):638-45
references.pmid: 16794571
references.citation: Alcohol Clin Exp Res. 1997 Oct;21(7):1285-93
references.pmid: 9347091